Page last updated: 2024-10-28

hydroxychloroquine and Eye Abnormalities

hydroxychloroquine has been researched along with Eye Abnormalities in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Eye Abnormalities: Congenital absence of or defects in structures of the eye; may also be hereditary.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kim, DA1
Rho, S1
Mulholland, CP1
Pollock, TJ1

Other Studies

2 other studies available for hydroxychloroquine and Eye Abnormalities

ArticleYear
Peters Anomaly in One Premature Twin Following Hydroxychloroquine Exposure During Pregnancy: A Case Report.
    Korean journal of ophthalmology : KJO, 2023, Volume: 37, Issue:3

    Topics: Anterior Eye Segment; Corneal Opacity; Eye Abnormalities; Female; Humans; Hydroxychloroquine; Pregna

2023
The Peters anomaly following antenatal exposure to methotrexate and hydroxychloroquine.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2011, Volume: 46, Issue:3

    Topics: Anterior Eye Segment; Antirheumatic Agents; Arthritis, Rheumatoid; Corneal Opacity; Enzyme Inhibitor

2011